Results
1 -
10 of
21
(Click
here to explore results)
- Anaplastic lymphoma kinase (ALK) inhibitors: a review of design and discovery. Wen-Chieh Wang, Hui-Yi Shiao, Chieh-Chien Lee, Ka-Shu Fung, Hsing-Pang Hsieh
, Med. Chem. Commun.
, 2014
, 5
, 1266
- A cascade dual-targeted nanocarrier for enhanced alectinib delivery to ALK-positive lung cancer. Fanjun Zeng, Bin Xu, Hongyuan Zhu, Shaowei Wu, Guoqing Liao, Daipeng Xie, Luyu Huang, Guibin Qiao, Xianzhu Yang, Haiyu Zhou
, Biomater. Sci.
, 2020
, 8
, 6404
- Latest perspectives of orally bioavailable 2,4-diarylaminopyrimidine analogues (DAAPalogues) as anaplastic lymphoma kinase inhibitors: discovery and clinical developments. Muhammad Latif, Zaman Ashraf, Sulman Basit, Abdul Ghaffar, Muhammad Sohail Zafar, Aamer Saeed, Sultan Ayoub Meo
, RSC Adv.
, 2018
, 8
, 16470
- Metastasis manners and the underlying mechanisms of ALK and ROS1 rearrangement lung cancer and current possible therapeutic strategies. Xing Chang, Zi Liu, Shuai Man, Annie Roys, Zengqiang Li, Daiying Zuo, Yingliang Wu
, RSC Adv.
, 2019
, 9
, 17921
- Nitrile-containing pharmaceuticals: target, mechanism of action, and their SAR studies. Xi Wang, Yuanxun Wang, Xuemin Li, Zhenyang Yu, Chun Song, Yunfei Du
, RSC Med. Chem.
, 2021
, 12
, 1650
- Indole-containing pharmaceuticals: targets, pharmacological activities, and SAR studies. Wei Zeng, Chi Han, Sarah Mohammed, Shanshan Li, Yixuan Song, Fengxia Sun, Yunfei Du
, RSC Med. Chem.
, 2024
, 15
, 788
- Computational methods directed towards drug repurposing for COVID-19: advantages and limitations. Prem Prakash Sharma, Meenakshi Bansal, Aaftaab Sethi, Poonam, Lindomar Pena, Vijay Kumar Goel, Maria Grishina, Shubhra Chaturvedi, Dhruv Kumar, Brijesh Rathi
, RSC Adv.
, 2021
, 11
, 36181
- Synthesis and photobiological applications of naphthalimide–benzothiazole conjugates: cytotoxicity and topoisomerase IIα inhibition. Iqubal Singh, Vijay Luxami, Diptiman Choudhury, Kamaldeep Paul
, RSC Adv.
, 2022
, 12
, 483
- Synthesis of new class of indole acetic acid sulfonate derivatives as ectonucleotidases inhibitors. Muhammad Siraj Khan Jadoon, Julie Pelletier, Jean Sévigny, Jamshed Iqbal
, RSC Adv.
, 2023
, 13
, 29496
- Structure-based design and analysis of SuFEx chemical probes. Lyn H. Jones, Jeffery W. Kelly
, RSC Med. Chem.
, 2020
, 11
, 10